Related Experiment Video
Updated: Oct 14, 2025

A Novel Method: Super-selective Adrenal Venous Sampling
Published on: September 15, 2017
Acute Illness and Death in Children With Adrenal Insufficiency
Chris Worth1, Avni Vyas2, Indraneel Banerjee1,2
1Department of Paediatric Endocrinology, Royal Manchester Children's Hospital, Manchester, United Kingdom.
Insights
Parents manage symptomatic Adrenal Insufficiency (AI) at home by increasing oral hydrocortisone but rarely use intramuscular injections during Adrenal Crisis (AC), despite training. New strategies are needed to improve parenteral hydrocortisone use in pediatric AI management.
Area of Science:
- Pediatric Endocrinology
- Adrenal Disorders Management
- Patient Education and Adherence
Background:
- Adrenal Insufficiency (AI) can precipitate life-threatening Adrenal Crises (AC) and Adrenal Death (AD).
- Parental education focuses on recognizing and reacting to AC, yet home management practices for symptomatic AI are under-documented.
- Understanding current parental practices is crucial for improving AC prevention and management in children.
Purpose of the Study:
- To investigate parental management strategies for symptomatic Adrenal Insufficiency at home.
- To assess the circumstances surrounding Adrenal Crises in children.
- To evaluate parent perceptions and utilization of parenteral hydrocortisone for AC.
Main Methods:
- Retrospective analysis of patient characteristics in children with Adrenal Death over 13 years.
- Interview-aided questionnaires assessing AC circumstances in pediatric patients.
- Separate study on parent perceptions of parenteral hydrocortisone administration.
Main Results:
- Adrenal Death incidence estimated at 1 per 300 patient-years; unspecified AI overrepresented.
- Common AC symptoms included nausea/vomiting (75%) and drowsiness (70%).
- Parents increased oral hydrocortisone but rarely administered intramuscular hydrocortisone, despite 79% confidence in the procedure.
Conclusions:
- Parental adherence to 'sick day' rules for oral hydrocortisone is observed, but intramuscular hydrocortisone use in AC is infrequent.
- Existing training programs for AC management appear insufficient to prevent severe crises.
- Novel strategies are required to promote the timely and appropriate use of parenteral hydrocortisone in pediatric Adrenal Insufficiency.
Background:
Adrenal Insufficiency (AI) can lead to life-threatening Adrenal Crisis (AC) and Adrenal Death (AD). Parents are trained to prevent, recognise and react to AC but there is little available information on what parents are actually doing at home to manage symptomatic AI.
Methods:
Three approaches were taken: (A) A retrospective analysis of patient characteristics in children and young people with AD over a 13-year period, (B) An interview-aided questionnaire to assess the circumstances around AC in children currently in our adrenal clinic, and (C) a separate study of parent perceptions of the administration of parenteral hydrocortisone.
Results:
Thirteen patients died (median age 10 years) over a thirteen-year period resulting in an estimated incidence of one AD per 300 patient years. Those with unspecified adrenal insufficiency were overrepresented (P = 0.004). Of the 127 patients contacted, thirty-eight (30%) were identified with hospital attendance with AC. Responses from twenty patients (median age 7.5 years) with AC reported nausea/vomiting (75%) and drowsiness (70%) as common symptoms preceding AC. All patients received an increase in oral hydrocortisone prior to admission but only two received intramuscular hydrocortisone. Questionnaires revealed that 79% of parents reported confidence in the administration of intramuscular hydrocortisone and only 20% identified a missed opportunity for injection.
Conclusions:
In children experiencing AC, parents followed 'sick day' guidance for oral hydrocortisone, but rarely administered intramuscular hydrocortisone. This finding is discrepant from the 79% of parents who reported confidence in this task. Local training programmes for management of AC are comprehensive, but insufficient to prevent the most serious crises. New strategies to encourage use of parenteral hydrocortisone need to be devised.
More Related Videos
Related Concept Videos
Adrenal Gland Disorders
Adrenal insufficiency, characterized by insufficient cortisol and aldosterone production, leads to conditions like Addison's disease. This disorder, affecting the adrenal cortex, exhibits symptoms such as skin bronzing, dehydration, low blood pressure, fatigue, and weight loss. Congenital adrenal hyperplasia, a genetic ailment causing...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury I: Introduction
Adrenergic Agonists: Therapeutic Uses
Emergency and Intensive Care Unit (ICU) applications: Pressor agents increase blood pressure, heart rate, and contractility in shock and organ failure situations. Dopamine can induce vasodilation and stimulate adrenoceptors. Endogenous catecholamines are effective in treating cardiogenic shock. α2-agonists like clonidine can reverse anesthesia-induced hypertension.
Allergies and...
Acute Kidney Injury IV: Diagnostic Studies and Prevention

